A USA Today report explores the growing national attention surrounding ibogaine, a psychoactive compound derived from the root of the iboga plant, traditionally used in West Africa. Although the substance remains illegal in the United States, researchers and policymakers have shown increasing interest in studying its potential therapeutic applications, particularly for conditions such as substance use disorder, traumatic brain injury, and PTSD.
The article highlights Texas’ recent decision to allocate $50 million for FDA-authorized clinical trials examining ibogaine’s safety and effectiveness. Advocates, including former Texas Governor Rick Perry and Americans for Ibogaine CEO Bryan Hubbard, have helped bring attention to the research effort, while scientists emphasize the need for rigorous studies to better understand the compound’s potential benefits as well as its known medical risks.